Year |
Citation |
Score |
2012 |
Mishra A, Liu S, Sams GH, Curphey DP, Santhanam R, Rush LJ, Schaefer D, Falkenberg LG, Sullivan L, Jaroncyk L, Yang X, Fisk H, Wu LC, Hickey C, Chandler JC, et al. Aberrant overexpression of IL-15 initiates large granular lymphocyte leukemia through chromosomal instability and DNA hypermethylation. Cancer Cell. 22: 645-55. PMID 23153537 DOI: 10.1016/J.Ccr.2012.09.009 |
0.488 |
|
2010 |
Mishra A, Liu S, Sams GH, Curphey DP, Santhanam R, Rush LJ, Schaefer D, Falkenberg LG, Sullivan L, Jaroncyk L, Zou X, Fisk H, Labanowska J, Caserta E, Wu L, et al. Interleukin-15 Is a Proto-Oncogene In Acute Large Granular Lymphocyte Leukemia Blood. 116: 704-704. DOI: 10.1182/Blood.V116.21.704.704 |
0.472 |
|
2009 |
Garzon R, Liu S, Fabbri M, Liu Z, Heaphy CE, Callegari E, Schwind S, Pang J, Yu J, Muthusamy N, Havelange V, Volinia S, Blum W, Rush LJ, Perrotti D, et al. MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1. Blood. 113: 6411-8. PMID 19211935 DOI: 10.1182/Blood-2008-07-170589 |
0.393 |
|
2009 |
Liu Z, Liu S, Xie Z, Pavlovicz RE, Wu J, Chen P, Aimiuwu J, Pang J, Bhasin D, Neviani P, Fuchs JR, Plass C, Li PK, Li C, Huang TH, ... ... Rush L, et al. Modulation of DNA methylation by a sesquiterpene lactone parthenolide. The Journal of Pharmacology and Experimental Therapeutics. 329: 505-14. PMID 19201992 DOI: 10.1124/Jpet.108.147934 |
0.476 |
|
2009 |
Chen WK, Swartz JD, Rush LJ, Alvarez CE. Mapping DNA structural variation in dogs. Genome Research. 19: 500-9. PMID 19015322 DOI: 10.1101/Gr.083741.108 |
0.333 |
|
2008 |
Whitman SP, Hackanson B, Liyanarachchi S, Liu S, Rush LJ, Maharry K, Margeson D, Davuluri R, Wen J, Witte T, Yu L, Liu C, Bloomfield CD, Marcucci G, Plass C, et al. DNA hypermethylation and epigenetic silencing of the tumor suppressor gene, SLC5A8, in acute myeloid leukemia with the MLL partial tandem duplication. Blood. 112: 2013-6. PMID 18566324 DOI: 10.1182/Blood-2008-01-128595 |
0.653 |
|
2007 |
Smiraglia DJ, Kazhiyur-Mannar R, Oakes CC, Wu YZ, Liang P, Ansari T, Su J, Rush LJ, Smith LT, Yu L, Liu C, Dai Z, Chen SS, Wang SH, Costello J, et al. Restriction landmark genomic scanning (RLGS) spot identification by second generation virtual RLGS in multiple genomes with multiple enzyme combinations. Bmc Genomics. 8: 446. PMID 18053125 DOI: 10.1186/1471-2164-8-446 |
0.334 |
|
2007 |
Brena RM, Morrison C, Liyanarachchi S, Jarjoura D, Davuluri RV, Otterson GA, Reisman D, Glaros S, Rush LJ, Plass C. Aberrant DNA methylation of OLIG1, a novel prognostic factor in non-small cell lung cancer. Plos Medicine. 4: e108. PMID 17388669 DOI: 10.1371/Journal.Pmed.0040108 |
0.327 |
|
2006 |
Dorrance AM, Liu S, Yuan W, Becknell B, Arnoczky KJ, Guimond M, Strout MP, Feng L, Nakamura T, Yu L, Rush LJ, Weinstein M, Leone G, Wu L, Ferketich A, et al. Mll partial tandem duplication induces aberrant Hox expression in vivo via specific epigenetic alterations. The Journal of Clinical Investigation. 116: 2707-16. PMID 16981007 DOI: 10.1172/Jci25546 |
0.683 |
|
2006 |
Whitman SP, Wen J, Muto G, Hackanson B, Yu L, Liu C, Sanfilippo JL, Marcucci G, Rush LJ, Plass C, Caligiuri MA. The Tumor Suppressor Gene SLC5A8 Is Selectively Silenced in MLL Partial Tandem Duplication-Positive Acute Myeloid Leukemia with Normal Cytogenetics. Blood. 108: 9-9. DOI: 10.1182/Blood.V108.11.9.9 |
0.656 |
|
2005 |
Whitman SP, Liu S, Vukosavljevic T, Rush LJ, Yu L, Liu C, Klisovic MI, Maharry K, Guimond M, Strout MP, Becknell B, Dorrance A, Klisovic RB, Plass C, Bloomfield CD, et al. The MLL partial tandem duplication: evidence for recessive gain-of-function in acute myeloid leukemia identifies a novel patient subgroup for molecular-targeted therapy. Blood. 106: 345-52. PMID 15774615 DOI: 10.1182/Blood-2005-01-0204 |
0.667 |
|
2005 |
Liu S, Shen T, Huynh L, Klisovic MI, Rush LJ, Ford JL, Yu J, Becknell B, Li Y, Liu C, Vukosavljevic T, Whitman SP, Chang KS, Byrd JC, Perrotti D, et al. Interplay of RUNX1/MTG8 and DNA methyltransferase 1 in acute myeloid leukemia. Cancer Research. 65: 1277-84. PMID 15735013 DOI: 10.1158/0008-5472.Can-04-4532 |
0.473 |
|
2004 |
Rush LJ, Raval A, Funchain P, Johnson AJ, Smith L, Lucas DM, Bembea M, Liu TH, Heerema NA, Rassenti L, Liyanarachchi S, Davuluri R, Byrd JC, Plass C. Epigenetic profiling in chronic lymphocytic leukemia reveals novel methylation targets. Cancer Research. 64: 2424-33. PMID 15059895 DOI: 10.1158/0008-5472.Can-03-2870 |
0.508 |
|
2004 |
Gurrieri C, Capodieci P, Bernardi R, Scaglioni PP, Nafa K, Rush LJ, Verbel DA, Cordon-Cardo C, Pandolfi PP. Loss of the tumor suppressor PML in human cancers of multiple histologic origins. Journal of the National Cancer Institute. 96: 269-79. PMID 14970276 DOI: 10.1093/Jnci/Djh043 |
0.385 |
|
2003 |
Dai Z, Zhu WG, Morrison CD, Brena RM, Smiraglia DJ, Raval A, Wu YZ, Rush LJ, Ross P, Molina JR, Otterson GA, Plass C. A comprehensive search for DNA amplification in lung cancer identifies inhibitors of apoptosis cIAP1 and cIAP2 as candidate oncogenes. Human Molecular Genetics. 12: 791-801. PMID 12651874 DOI: 10.1093/Hmg/Ddg083 |
0.384 |
|
2003 |
Klisovic MI, Maghraby EA, Parthun MR, Guimond M, Sklenar AR, Whitman SP, Chan KK, Murphy T, Anon J, Archer KJ, Rush LJ, Plass C, Grever MR, Byrd JC, Marcucci G. Depsipeptide (FR 901228) promotes histone acetylation, gene transcription, apoptosis and its activity is enhanced by DNA methyltransferase inhibitors in AML1/ETO-positive leukemic cells Leukemia. 17: 350-358. PMID 12592335 DOI: 10.1038/Sj.Leu.2402776 |
0.52 |
|
2003 |
Smiraglia DJ, Smith LT, Lang JC, Rush LJ, Dai Z, Schuller DE, Plass C. Differential targets of CpG island hypermethylation in primary and metastatic head and neck squamous cell carcinoma (HNSCC). Journal of Medical Genetics. 40: 25-33. PMID 12525538 DOI: 10.1136/Jmg.40.1.25 |
0.424 |
|
2002 |
Dai Z, Weichenhan D, Wu YZ, Hall JL, Rush LJ, Smith LT, Raval A, Yu L, Kroll D, Muehlisch J, Frühwald MC, de Jong P, Catanese J, Davuluri RV, Smiraglia DJ, et al. An AscI boundary library for the studies of genetic and epigenetic alterations in CpG islands. Genome Research. 12: 1591-8. PMID 12368252 DOI: 10.1101/Gr.197402 |
0.477 |
|
2002 |
Rush LJ, Plass C. Restriction landmark genomic scanning for DNA methylation in cancer: past, present, and future applications. Analytical Biochemistry. 307: 191-201. PMID 12202234 DOI: 10.1016/S0003-2697(02)00033-7 |
0.465 |
|
2002 |
Rush LJ, Plass C. Alterations of DNA methylation in hematologic malignancies. Cancer Letters. 185: 1-12. PMID 12142073 DOI: 10.1016/S0304-3835(02)00288-4 |
0.509 |
|
2002 |
Rush LJ, Heinonen K, Mrózek K, Wolf BJ, Abdel-Rahman M, Szymanska J, Peltomäki P, Kapadia F, Bloomfield CD, Caligiuri MA, Plass C. Comprehensive cytogenetic and molecular genetic characterization of the TI-1 acute myeloid leukemia cell line reveals cross-contamination with K-562 cell line. Blood. 99: 1874-6. PMID 11871388 DOI: 10.1182/Blood.V99.5.1874 |
0.488 |
|
2001 |
Tanner SM, Austin JL, Leone G, Rush LJ, Plass C, Heinonen K, Mrózek K, Sill H, Knuutila S, Kolitz JE, Archer KJ, Caligiuri MA, Bloomfield CD, de La Chapelle A. BAALC, the human member of a novel mammalian neuroectoderm gene lineage, is implicated in hematopoiesis and acute leukemia. Proceedings of the National Academy of Sciences of the United States of America. 98: 13901-6. PMID 11707601 DOI: 10.1073/Pnas.241525498 |
0.579 |
|
2001 |
Dai Z, Lakshmanan RR, Zhu WG, Smiraglia DJ, Rush LJ, Frühwald MC, Brena RM, Li B, Wright FA, Ross P, Otterson GA, Plass C. Global methylation profiling of lung cancer identifies novel methylated genes. Neoplasia (New York, N.Y.). 3: 314-23. PMID 11571631 DOI: 10.1038/Sj.Neo.7900162 |
0.473 |
|
2001 |
Smiraglia DJ, Rush LJ, Frühwald MC, Dai Z, Held WA, Costello JF, Lang JC, Eng C, Li B, Wright FA, Caligiuri MA, Plass C. Excessive CpG island hypermethylation in cancer cell lines versus primary human malignancies Human Molecular Genetics. 10: 1413-1419. PMID 11440994 DOI: 10.1093/Hmg/10.13.1413 |
0.526 |
|
2001 |
Rush LJ, Dai Z, Smiraglia DJ, Gao X, Wright FA, Frühwald M, Costello JF, Held WA, Yu L, Krahe R, Kolitz JE, Bloomfield CD, Caligiuri MA, Plass C. Novel methylation targets in de novo acute myeloid leukemia with prevalence of chromosome 11 loci. Blood. 97: 3226-33. PMID 11342453 DOI: 10.1182/Blood.V97.10.3226 |
0.616 |
|
2001 |
Frühwald MC, O'Dorisio MS, Dai Z, Rush LJ, Krahe R, Smiraglia DJ, Pietsch T, Elsea SH, Plass C. Aberrant hypermethylation of the major breakpoint cluster region in 17p11.2 in medulloblastomas but not supratentorial PNETs. Genes, Chromosomes & Cancer. 30: 38-47. PMID 11107174 DOI: 10.1002/1098-2264(2000)9999:9999<::Aid-Gcc1052>3.0.Co;2-S |
0.461 |
|
2001 |
Plass C, Frühwald MC, Rush LJ, Dai Z, Smith LT, Smiraglia DJ. Contribution of DNA methylation to oncogenesis: Results of a genome scanning approach in multiple human tumors Nature Genetics. 27: 80-80. DOI: 10.1038/87252 |
0.399 |
|
2000 |
Costello JF, Frühwald MC, Smiraglia DJ, Rush LJ, Robertson GP, Gao X, Wright FA, Feramisco JD, Peltomäki P, Lang JC, Schuller DE, Yu L, Bloomfield CD, Caligiuri MA, Yates A, et al. Aberrant CpG-island methylation has non-random and tumour-type-specific patterns. Nature Genetics. 24: 132-8. PMID 10655057 DOI: 10.1038/72785 |
0.585 |
|
Show low-probability matches. |